1992
|
Sign up to set email alerts
Mycosis Fungoides of the Larynx: Report of Two Cases and Review of the Literature
Search citation statements
Order By: Relevance
Paper Sections
Select...
15
3
2
0
Citation Types
0
14
0
0
Year Published
1995
19952025
2025Publication Types
Select...
18
Relationship
0
18
Authors
Journals
Cited by 18 publications
(14 citation statements)
References 24 publications
0
14
0
0
Order By: Relevance
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…There are a total of 43 cases that explicitly mention prior therapies received before the development of oral lesions. Of these, 13 cases (30%) received TSEBT (TSEBT group) [ 27 , 28 , 31 , 35 , 36 , 38 , 44 – 46 , 54 , 55 , 57 ] and 30 cases (70%) did not receive TSEBT (non-TSEBT group) [ 13 , 15 , 16 , 19 , 21 , 22 , 26 , 29 , 33 , 34 , 36 , 37 , 39 , 42 , 43 , 45 , 47 – 50 , 52 , 53 , 56 , 58 , 60 – 63 ] prior to developing oral lesions. The time for oral CTCL to develop after the initial presentation of CTCL was 5.4 years and 7.3 years for the TSEBT and the non-TSEBT groups, respectively.…”
Section: Discussion/conclusion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…There are a total of 43 cases that explicitly mention prior therapies received before the development of oral lesions. Of these, 13 cases (30%) received TSEBT (TSEBT group) [ 27 , 28 , 31 , 35 , 36 , 38 , 44 – 46 , 54 , 55 , 57 ] and 30 cases (70%) did not receive TSEBT (non-TSEBT group) [ 13 , 15 , 16 , 19 , 21 , 22 , 26 , 29 , 33 , 34 , 36 , 37 , 39 , 42 , 43 , 45 , 47 – 50 , 52 , 53 , 56 , 58 , 60 – 63 ] prior to developing oral lesions. The time for oral CTCL to develop after the initial presentation of CTCL was 5.4 years and 7.3 years for the TSEBT and the non-TSEBT groups, respectively.…”
Section: Discussion/conclusion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Redleaf et al 9 published a report on a patient with a chief complaint of both dysphagia and hoarseness, and endoscopy with subsequent biopsy was consistent with MF. Kuhn et al 6 published a series of two patients with laryngeal MF and a presentation of hoarseness, with one patient also endorsing dysphagia. Maleki and Azmi8 reported on a patient with MF of the true vocal cord and subglottic region who presented with both dysphagia and hoarseness.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Ferlito and Recher (1986) reported the laryngeal tumour as the first visceral manifestation of the disease, with later widespread dissemination to lung, liver, and lymph nodes. Kuhn et al (1992) presented two cases of laryngeal MF, one of whom presented with vocal fold paresis (progressing to paralysis). Gordon et al (1992) reported a case of laryngeal involvement of MF as the earliest extracutaneous manifestation.…”
Section: Discussion
mentioning
confidence: 99%
“…The prognosis of MF and CD30 negative cutaneous lymphomas is poor once dissemination has occurred (Block et al, 1963;Merlo, 1987;Suasville etal, 1988;Willemze et al, 1994). In all six cases of cutaneous T-cell lymphoma presenting in the larynx that were followed up (Hood et al, 1979;Ferlito and Recher, 1986;Gordon et al, 1992;Kuhn et al, 1992), the patient «1 2^3 4 5r 6 7 8 9 1011 12 13…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…There are a total of 43 cases that explicitly mention prior therapies received before the development of oral lesions. Of these, 13 cases (30%) received TSEBT (TSEBT group) [ 27 , 28 , 31 , 35 , 36 , 38 , 44 – 46 , 54 , 55 , 57 ] and 30 cases (70%) did not receive TSEBT (non-TSEBT group) [ 13 , 15 , 16 , 19 , 21 , 22 , 26 , 29 , 33 , 34 , 36 , 37 , 39 , 42 , 43 , 45 , 47 – 50 , 52 , 53 , 56 , 58 , 60 – 63 ] prior to developing oral lesions. The time for oral CTCL to develop after the initial presentation of CTCL was 5.4 years and 7.3 years for the TSEBT and the non-TSEBT groups, respectively.…”
Section: Discussion/conclusion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Redleaf et al 9 published a report on a patient with a chief complaint of both dysphagia and hoarseness, and endoscopy with subsequent biopsy was consistent with MF. Kuhn et al 6 published a series of two patients with laryngeal MF and a presentation of hoarseness, with one patient also endorsing dysphagia. Maleki and Azmi8 reported on a patient with MF of the true vocal cord and subglottic region who presented with both dysphagia and hoarseness.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Ferlito and Recher (1986) reported the laryngeal tumour as the first visceral manifestation of the disease, with later widespread dissemination to lung, liver, and lymph nodes. Kuhn et al (1992) presented two cases of laryngeal MF, one of whom presented with vocal fold paresis (progressing to paralysis). Gordon et al (1992) reported a case of laryngeal involvement of MF as the earliest extracutaneous manifestation.…”
Section: Discussion
mentioning
confidence: 99%
“…The prognosis of MF and CD30 negative cutaneous lymphomas is poor once dissemination has occurred (Block et al, 1963;Merlo, 1987;Suasville etal, 1988;Willemze et al, 1994). In all six cases of cutaneous T-cell lymphoma presenting in the larynx that were followed up (Hood et al, 1979;Ferlito and Recher, 1986;Gordon et al, 1992;Kuhn et al, 1992), the patient «1 2^3 4 5r 6 7 8 9 1011 12 13…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…There are a total of 43 cases that explicitly mention prior therapies received before the development of oral lesions. Of these, 13 cases (30%) received TSEBT (TSEBT group) [ 27 , 28 , 31 , 35 , 36 , 38 , 44 – 46 , 54 , 55 , 57 ] and 30 cases (70%) did not receive TSEBT (non-TSEBT group) [ 13 , 15 , 16 , 19 , 21 , 22 , 26 , 29 , 33 , 34 , 36 , 37 , 39 , 42 , 43 , 45 , 47 – 50 , 52 , 53 , 56 , 58 , 60 – 63 ] prior to developing oral lesions. The time for oral CTCL to develop after the initial presentation of CTCL was 5.4 years and 7.3 years for the TSEBT and the non-TSEBT groups, respectively.…”
Section: Discussion/conclusion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Redleaf et al 9 published a report on a patient with a chief complaint of both dysphagia and hoarseness, and endoscopy with subsequent biopsy was consistent with MF. Kuhn et al 6 published a series of two patients with laryngeal MF and a presentation of hoarseness, with one patient also endorsing dysphagia. Maleki and Azmi8 reported on a patient with MF of the true vocal cord and subglottic region who presented with both dysphagia and hoarseness.…”
Section: Discussion
mentioning
confidence: 99%
Abstract
Smart CitationsHow this paper cites the one you are viewing
“…Ferlito and Recher (1986) reported the laryngeal tumour as the first visceral manifestation of the disease, with later widespread dissemination to lung, liver, and lymph nodes. Kuhn et al (1992) presented two cases of laryngeal MF, one of whom presented with vocal fold paresis (progressing to paralysis). Gordon et al (1992) reported a case of laryngeal involvement of MF as the earliest extracutaneous manifestation.…”
Section: Discussion
mentioning
confidence: 99%
“…The prognosis of MF and CD30 negative cutaneous lymphomas is poor once dissemination has occurred (Block et al, 1963;Merlo, 1987;Suasville etal, 1988;Willemze et al, 1994). In all six cases of cutaneous T-cell lymphoma presenting in the larynx that were followed up (Hood et al, 1979;Ferlito and Recher, 1986;Gordon et al, 1992;Kuhn et al, 1992), the patient «1 2^3 4 5r 6 7 8 9 1011 12 13…”
Section: Discussion
mentioning
confidence: 99%
Scite is an AI-powered platform that helps researchers discover and evaluate scientific literature through Smart Citations, showing whether studies support or contradict a claim. Now part of Research Solutions, Scite has indexed 1.6B+ citations, partners with 30+ publishers, and serves 2M users worldwide.
Resources
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2026 Scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.
